marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Frequency Therapeutics Financial Ratios 2011-2024 | FREQ
Annual Financial Ratios Frequency Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.3 | -0.0 | -2.1 | -49.7 | -10.9 | - | - | - | - | - | - | - | - |
P/S |
- | - | 12.6 | 35.6 | 7.1 | - | - | - | - | - | - | - | - |
EPS |
-53.1 | -227.4 | - | -0.8 | -2.3 | -12.5 | -28.8 | - | - | - | - | - | - |
EV (Enterprise Value) |
-91.5 M | -27.3 M | 152 M | 1.17 B | 60.3 M | 92.8 M | 49.4 M | - | - | - | - | - | - |
EBITDA per Share |
-52.9 | -221 | -2.35 | -0.792 | -2.3 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-1.8 | -42.7 | -0.2 | - | - | - | - | - | - | - | - | ||
PEG |
- | -1.47 | -0.25 | - | - | - | - | - | - | - | - | ||
P/B |
0.1 | 0.0 | 1.4 | 6.8 | 1.2 | - | - | - | - | - | - | - | - |
P/CF |
-0.3 | -0.0 | -2.3 | -25.4 | 6.2 | - | - | - | - | - | - | - | - |
ROE % |
-47.77 | 58.60 | -64.73 | -13.77 | -11.20 | - | - | - | - | - | - | - | - |
ROA % |
-36.62 | -78.70 | -45.69 | -10.01 | -8.40 | - | - | - | - | - | - | - | - |
ROCE % |
-49.75 | 59.58 | -64.23 | -11.57 | -12.13 | - | - | - | - | - | - | - | - |
Current Ratio |
4.3 | 8.3 | 3.4 | 8.5 | 4.2 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | 3.4 | 10.2 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Frequency Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.26 | -2.43 | -2.44 | - | -65.08 | -63.83 | -72.2 | - | -0.55 | -0.61 | -0.67 | - | -0.73 | -0.52 | -0.6 | -0.3 | -0.16 | -0.19 | -0.16 | -0.19 | -0.73 | -3.42 | -3.24 | -3.23 | -3.26 | -3.01 | -3.03 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -2.58 | - | -66 | -64.8 | -71 | - | -0.56 | -0.59 | -0.65 | - | -0.7 | -0.48 | -0.58 | - | -0.15 | -0.19 | -0.18 | - | -0.48 | -3.44 | -3.2 | - | -3.12 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-23.56 | 0.19 | 24.25 | 41.68 | 17.84 | -18.07 | -53.32 | -66.81 | -83.91 | -77.16 | -65.59 | -39.22 | -44.53 | -30.21 | -22.71 | -13.77 | -11.74 | -9.31 | -10.27 | -11.20 | 3.36 | 14.34 | 30.10 | 33.59 | 22.30 | 11.67 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-67.14 | -98.42 | -111.91 | -81.45 | -95.82 | -70.29 | -62.28 | -42.77 | -55.21 | -53.28 | -47.08 | -28.90 | -32.76 | -22.34 | -16.60 | -10.01 | -8.61 | -6.85 | -7.64 | -8.40 | -18.16 | -29.44 | -26.37 | -23.76 | -11.53 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-26.83 | -1.37 | 24.41 | 43.08 | 18.34 | -18.88 | -54.67 | -67.57 | -84.56 | -76.81 | -65.15 | -38.90 | -41.72 | -27.54 | -20.24 | -8.97 | -9.72 | -7.65 | -8.63 | -8.48 | 2.00 | 13.22 | 17.41 | 10.47 | 10.47 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
3.8 | 4.8 | 4.2 | 4.3 | 4.8 | 2.3 | 2.1 | 2.3 | 2.5 | 2.8 | 3.2 | 3.4 | 3.7 | 4.1 | 3.8 | 3.7 | 3.7 | 3.7 | 3.7 | 4.0 | 4.0 | 4.0 | 4.0 | 10.8 | 10.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency